Sage Therapeutics, Inc. Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promotion Letter Agreement by and between the Registrant and Christopher Benecchi, effective November 1, 2024
Sage Therapeutics, Inc.
Biotechnology
2025
Promotion Letter Agreement by and between the Registrant and Gregory Shiferman, effective November 1, 2024
Sage Therapeutics, Inc.
Biotechnology
2025
Amendment to Amended and Restated 2016 Inducement Equity Plan
Sage Therapeutics, Inc.
Biotechnology
2024
Amendment to Amended and Restated 2016 Inducement Equity Plan
Sage Therapeutics, Inc.
Biotechnology
2024
Offer Letter by and between the Registrant and Christopher Benecchi, dated September 13, 2021
Sage Therapeutics, Inc.
Biotechnology
2021
Description of Securities
Sage Therapeutics, Inc.
Biotechnology
2020
Amended and Restated 2016 Inducement Equity Plan and forms of agreements thereunder, as amended and restated on September 20, 2018
Sage Therapeutics, Inc.
Biotechnology
DE
2018
Offer letter by and between the Registrant and Michael Cloonan, dated March 21, 2017
Sage Therapeutics, Inc.
Biotechnology
2017
Sage Therapeutics
Sage Therapeutics, Inc.
Biotechnology
2016
P ###-###-#### F ###-###-#### 215 First Street, Cambridge, MA 02142
Sage Therapeutics, Inc.
Biotechnology
2014
Sage Therapeutics, Inc.
Sage Therapeutics, Inc.
Biotechnology
2014
Sage Therapeutics, Inc.
Sage Therapeutics, Inc.
Biotechnology
2014
Sage Therapeutics, Inc.
Sage Therapeutics, Inc.
Biotechnology
2014